Search - tctmd.com

Displaying 501 - 520 of 589

Sort: Relevancy | Date

News Daily News

New USPSTF Guidelines Recommend Statins in ‘Appropriately Selected’ Primary-Prevention Patients

Michael O'Riordan

November 13, 2016

News Conference News AHA 2016

Cardiac Arrest Survival Higher in Patients Already Taking Statins

Todd Neale

November 12, 2016

News Daily News

High-Intensity Statin Therapy Offers Survival Benefit Over Moderate-Intensity Statins in CVD Patients

Michael O'Riordan

November 10, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2016

Caitlin E. Cox

October 29, 2016

News Daily News

FH Screening Started at Time of Childhood Immunization Feasible and Effective

Michael O'Riordan

October 28, 2016

News Daily News

社会经济地位可能会影响男性他汀类药物的依从性，女性结果不明

Yael L. Maxwell

October 25, 2016

News Daily News

Socioeconomic Standing May Affect Statin Adherence in Men, With Unclear Consequences in Women

Yael L. Maxwell

October 25, 2016

News Daily News

La Situación Socioeconómica podría Afectar a la Adherencia a las Estatinas en Hombres, Con Consecuencias Poco Claras en Mujeres

Yael L. Maxwell

October 25, 2016

News Daily News

La AHA Facilita las Interacciones Farmacológicas entre Estatinas y Fármacos contra la Enfermedad Cardiovascular

Michael O'Riordan

October 18, 2016

News Daily News

AHA 提供他汀类药物和心血管药物药物相互作用指导

Michael O'Riordan

October 18, 2016

News Daily News

AHA Provides Guidance on Drug-Drug Interactions With Statins and CVD Medications

Michael O'Riordan

October 18, 2016

News Daily News

Use of Evidence-Based Medical Therapy Steadily Improving in Acute MI Patients Postdischarge

Michael O'Riordan

September 30, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2016

Shelley Wood

September 30, 2016

News Daily News

Pharmacist Management of High Cholesterol Gets More Patients to Goal, Lowers LDL Levels: RxACT

Michael O'Riordan

September 29, 2016

News Daily News

Lowering LDL With Statins and Other Selected Agents Should Be Focus of CVD Risk Reduction, Analysis Implies

Michael O'Riordan

September 27, 2016

News Daily News

CAC Screening Stratifies CVD Event Risk in Statin-Eligible Patients: Heinz Nixdorf Recall Study

Michael O'Riordan

September 22, 2016

News Daily News

Evolocumab Modifies IVUS-Detected Coronary Atherosclerosis: Topline Results From GLAGOV

Michael O'Riordan

September 20, 2016

News Industry News

Amgen Announces Positive Top-Line Results From Phase 3 GLAGOV Imaging Study Of Repatha® (Evolocumab)

September 20, 2016

News Daily News

英国人的战役：英国医学杂志、柳叶刀继续抨击他汀类药物

Todd Neale

September 19, 2016

News Daily News

Guerra de los Medios Británicos: BMJ, Lancet Siguen Recortando el Uso de Estatinas

Todd Neale

September 19, 2016

Advertisement

New USPSTF Guidelines Recommend Statins in ‘Appropriately Selected’ Primary-Prevention Patients

Cardiac Arrest Survival Higher in Patients Already Taking Statins

High-Intensity Statin Therapy Offers Survival Benefit Over Moderate-Intensity Statins in CVD Patients

TCTMD’s Top 10 Most Popular Stories for October 2016

FH Screening Started at Time of Childhood Immunization Feasible and Effective

社会经济地位可能会影响男性他汀类药物的依从性，女性结果不明

Socioeconomic Standing May Affect Statin Adherence in Men, With Unclear Consequences in Women

La Situación Socioeconómica podría Afectar a la Adherencia a las Estatinas en Hombres, Con Consecuencias Poco Claras en Mujeres

La AHA Facilita las Interacciones Farmacológicas entre Estatinas y Fármacos contra la Enfermedad Cardiovascular

AHA 提供他汀类药物和心血管药物药物相互作用指导

AHA Provides Guidance on Drug-Drug Interactions With Statins and CVD Medications

Use of Evidence-Based Medical Therapy Steadily Improving in Acute MI Patients Postdischarge

TCTMD’s Top 10 Most Popular Stories for September 2016

Pharmacist Management of High Cholesterol Gets More Patients to Goal, Lowers LDL Levels: RxACT

Lowering LDL With Statins and Other Selected Agents Should Be Focus of CVD Risk Reduction, Analysis Implies

CAC Screening Stratifies CVD Event Risk in Statin-Eligible Patients: Heinz Nixdorf Recall Study

Evolocumab Modifies IVUS-Detected Coronary Atherosclerosis: Topline Results From GLAGOV

Amgen Announces Positive Top-Line Results From Phase 3 GLAGOV Imaging Study Of Repatha® (Evolocumab)

英国人的战役：英国医学杂志、柳叶刀继续抨击他汀类药物

Guerra de los Medios Británicos: BMJ, Lancet Siguen Recortando el Uso de Estatinas

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content